循环吐综合征:从病理生理学到治疗
R A Jiménez-Castillo1, R Frazier2, T Venkatesan3
1Servicio de Gastroenterología y Endoscopía Digestiva, Hospital Universitario «Dr. José E. González», Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Revista de gastroenterologia de Mexico (English)
|July 21, 2024
概括
循环吐综合征 (CVS) 涉及反复出现的吐发作. 研究探讨了它的原因,诊断和管理,强调了个性化,多学科治疗方法的需要.
科学领域:
- 胃肠病学 胃肠病学
- 儿科 儿科 儿科
- 神经学 神经学
背景情况:
- 循环吐综合征 (CVS) 是一种经常性,强烈的吐发作的疾病.
- 主要影响儿童和青少年,但可以持续到成年.
- 对患者的生活质量产生重大影响.
研究的目的:
- 审查CVS的流行病学,病理生理学,亚型,诊断标准和管理.
- 检查假设的触发因素,包括遗传,神经系统和环境因素.
- 讨论当前的诊断挑战和治疗策略.
主要方法:
- 关于CVS的最近研究的文献综述.
- 对流行病学数据的分析.
- 综合当前对病理生理学和管理的理解.
主要成果:
- 病因仍然未知;潜在的触发因素包括遗传因素,自主失调和大麻素使用.
- 没有特定的诊断测试存在,需要彻底的症状评估和排除其他原因.
- 管理涉及一个多学科的方法与药物和心理疗法.
结论:
- 肺复苏症带来了诊断和治疗方面的挑战.
- 个性化治疗对于改善患者治疗结果至关重要.
- 为了更有效的策略,需要进一步的研究.
相关概念视频
Pathophysiology of Vomiting
366
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
366
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
191
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
191
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
244
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
244
Gastritis III: Clinical Manifestations and Management
204
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
204
Gastroesophageal Reflux Disease II: Clinical Features and Management
68
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
68


